» Articles » PMID: 39143072

Association Between Fast Eating Speed and Metabolic Dysfunction-associated Steatotic Liver Disease: a Multicenter Cross-sectional Study and Meta-analysis

Abstract

Background: With the fast pace of modern life, people have less time for meals, but few studies have examined the association between the habit of fast eating and metabolic diseases.

Objective: Combining the results of the current study and the prior ones, we aimed to investigate the possible relationship between fast eating and the risk of metabolic dysfunction-associated steatotic liver disease (MASLD).

Methods: This is a sub-analysis of a multicenter cross-sectional study of 1965 participants investigated the association between fast eating and MASLD in Chinese. Fast eating was defined as meal time less than five minutes and participants were divided into three categories based on their self-reported frequency of fast eating: ≤1 time/month, ≤1 time/week and ≥2 times/week. We further conducted a literature search for available studies published before November, 2023 as well as a meta-analysis to investigate the association between fast eating and MASLD.

Results: The proportion of MASLD was 59.3%, 50.5%, and 46.2% in participants with fast eating ≥2 times/week, ≤1 time/week and ≤1 time/month, respectively (P for trend <0.001). The frequency of fast eating was independently associated with risk of MASLD after multiple adjustment for sex, age, demographics, smoking and drinking status, BMI and clinical metabolic parameters (OR, 1.29; 95%CI, 1.09-1.53). Participants who ate fast frequently (≥2 times/week) had 81% higher risk of MASLD (P = 0.011). A meta-analysis of five eligible studies confirmed that frequent fast eating was associated with increased risk of MASLD (pooled OR, 1.22; 95%CI, 1.07-1.39).

Conclusions: Frequent fast eating was associated with an increased risk of MASLD.

Citing Articles

Circadian Deregulation: Back Facing the Sun Toward Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development.

Verdelho Machado M Nutrients. 2025; 16(24.

PMID: 39770915 PMC: 11679855. DOI: 10.3390/nu16244294.


Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD: Jordan's Perspective Based on Knowledge and Attitude Determinants.

Alqudah O, Alshahwan H, Alsamhouri J, Yamin S, Kaffaf A, Alassaf M Risk Manag Healthc Policy. 2024; 17:2483-2491.

PMID: 39463728 PMC: 11512787. DOI: 10.2147/RMHP.S481401.

References
1.
Leeuwendaal N, Cryan J, Schellekens H . Gut peptides and the microbiome: focus on ghrelin. Curr Opin Endocrinol Diabetes Obes. 2021; 28(2):243-252. PMC: 7924980. DOI: 10.1097/MED.0000000000000616. View

2.
Mansour-Ghanaei R, Mansour-Ghanaei F, Naghipour M, Joukar F . The Lifestyle Characteristics in Non-Alcoholic Fatty Liver Disease in the PERSIAN Guilan Cohort Study. Open Access Maced J Med Sci. 2020; 7(19):3313-3318. PMC: 6953935. DOI: 10.3889/oamjms.2019.647. View

3.
Yuan S, Liu Y, Liang W, Li F, Zeng Y, Liu Y . Association Between Eating Speed and Metabolic Syndrome: A Systematic Review and Meta-Analysis. Front Nutr. 2021; 8:700936. PMC: 8564065. DOI: 10.3389/fnut.2021.700936. View

4.
Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L . Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology. 2015; 149(2):367-78.e5. DOI: 10.1053/j.gastro.2015.04.005. View

5.
Chalasani N, Younossi Z, Lavine J, Charlton M, Cusi K, Rinella M . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2017; 67(1):328-357. DOI: 10.1002/hep.29367. View